2008 - Ph.D in Cellular and Molecular Pathology, University of Parma, Italy.
1998 - Degree in Biological Sciences, University of Milan, Italy.
In 2006 he moved to the Ludwing Institute of Cancer Research in Brussels where he worked on fundamental aspects of anti-tumor immune response in human melanoma.
In 2011 he joined the group of Prof. David Thomas at the Peter MacCallum Cancer Centre in Melbourne to study the mechanisms driving adaptive mutagenesis of human cancer cells in response to pharmacologic pressures.
He is currently Senior Research Officer in the Genomic Cancer Medicine Laboratory at the Kinghorn Cancer Centre in Sydney directed by Prof. David Thomas.
Dr Cipponi’s interests include:
Tour de Cure Pioneering Research Grant
NHMRC research grant
Foundation Grant, Peter MacCallum Cancer Institute, Melbourne Australia.
Belgian National Founds for Scientific Research (FNRS)
One of the main interests of the laboratory is to shed light on the hard-wired genetic and molecular mechanisms that are at the basis of the forces promoting adaptive strategies of human cancer cells in response to pharmacological and physiological stresses.
Additional projects are focused on: